pubmed.ncbi.nlm.nih.gov

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings - PubMed

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings

M A Burdt et al. Arthritis Rheum. 1999 May.

Free article

Abstract

Objective: To determine the long-term clinical and immunologic outcomes in a well-characterized cohort of 47 patients with mixed connective tissue disease (MCTD), including reactivity with U small nuclear RNP (snRNP) polypeptides.

Methods: Patients were followed up over a period of 3-29 years with immunogenetic and systematic clinical and serologic analysis. Sera were analyzed for reactivity with snRNP polypeptides U1-70 kd, A, C, B/B', and D, for anti-U1 RNA, and for anticardiolipin antibodies (aCL).

Results: The typical core clinical features of MCTD tended to develop over time; features of inflammation as well as Raynaud's phenomenon and esophageal hypomotility diminished, while pulmonary hypertension, pulmonary dysfunction, and central nervous system disease persisted, following treatment. A favorable outcome was observed in 62% of patients; 38% had continued active disease or had died, with death associated with pulmonary hypertension and aCL. All patients had autoantibodies to the U1-70 kd polypeptide of snRNP, and most were positive for anti-U1 RNA. An orderly progression of intramolecular spreading of autoantibody reactivity against snRNP polypeptides was observed, as was the novel finding of "epitope contraction" followed by disappearance of anti-snRNP autoantibodies during prolonged remission.

Conclusion: These patients demonstrated the typical immunogenetic, clinical, and serologic findings of MCTD, and the condition rarely evolved into systemic lupus erythematosus or systemic sclerosis. The majority of patients had favorable outcomes, with pulmonary hypertension being the most frequent disease-associated cause of death. Intramolecular spreading of autoantibody reactivity against snRNP polypeptides was observed, followed by "epitope contraction" and ultimate disappearance of anti-snRNP autoantibodies during prolonged disease remission.

PubMed Disclaimer

Cited by

Isolated central nervous system vasculitis associated with antiribonuclear protein antibody.
Awad AM, Stevenson M. Awad AM, et al. Case Rep Neurol Med. 2011;2011:495201. doi: 10.1155/2011/495201. Epub 2011 Jul 14. Case Rep Neurol Med. 2011. PMID: 22937341 Free PMC article.
2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Huang WC, Hsieh SC, Wu YW, Hsieh TY, Wu YJ, Li KJ, Charng MJ, Chen WS, Sung SH, Tsao YP, Ho WJ, Lai CC, Cheng CC, Tsai HC, Hsu CH, Lu CH, Chiu YW, Shen CY, Wu CH, Liu FC, Lin YH, Yeh FC, Liu WS, Lee HT, Wu SH, Chang CC, Chu CY, Hou CJ, Tsai CY. Huang WC, et al. Acta Cardiol Sin. 2023 Mar;39(2):213-241. doi: 10.6515/ACS.202303_39(2).20230117A. Acta Cardiol Sin. 2023. PMID: 36911549 Free PMC article.
Antibodies in scleroderma: direct pathogenicity and phenotypic associations.
Chung L, Utz PJ. Chung L, et al. Curr Rheumatol Rep. 2004 Apr;6(2):156-63. doi: 10.1007/s11926-004-0061-9. Curr Rheumatol Rep. 2004. PMID: 15016347 Review.
[Pulmonary arterial hypertension in collagenoses].
Claussen M, Riemekasten G, Hoeper MM. Claussen M, et al. Z Rheumatol. 2009 Oct;68(8):630-2, 634-8. doi: 10.1007/s00393-009-0480-0. Z Rheumatol. 2009. PMID: 19593574 Review. German.
Connective tissue disease-associated lung disease in children.
Schapiro AH, Morin CE, Wikenheiser-Brokamp KA, Tanimoto AA. Schapiro AH, et al. Pediatr Radiol. 2024 Jun;54(7):1059-1074. doi: 10.1007/s00247-024-05962-0. Epub 2024 Jun 8. Pediatr Radiol. 2024. PMID: 38850285 Free PMC article. Review.

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings - PubMed